Characterizing drug-related adverse events by joint analysis of biomedical and genomic data: A case study of drug-induced pulmonary fibrosis.
about
Characterizing drug-related adverse events by joint analysis of biomedical and genomic data: A case study of drug-induced pulmonary fibrosis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Characterizing drug-related ad ...... ug-induced pulmonary fibrosis.
@en
Characterizing drug-related ad ...... ug-induced pulmonary fibrosis.
@nl
type
label
Characterizing drug-related ad ...... ug-induced pulmonary fibrosis.
@en
Characterizing drug-related ad ...... ug-induced pulmonary fibrosis.
@nl
prefLabel
Characterizing drug-related ad ...... ug-induced pulmonary fibrosis.
@en
Characterizing drug-related ad ...... ug-induced pulmonary fibrosis.
@nl
P2860
P1433
P1476
Characterizing drug-related ad ...... ug-induced pulmonary fibrosis.
@en
P2093
Alex Jiang
Anil G Jegga
P2860
P577
2018-05-18T00:00:00Z